Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

TBI/Ratg-Based Conditioning for Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in 11 Cases of Chemotherapy-Resistant Advanced-Stage Peripheral T-Cell Lymphoma

JUN Zhu, Rong Xu, Chun Wang, Chuxian Zhao, Ying Jiang, Daolin Wei, Shan Shao, Huixia Liu, Su Li

Blood (2023) 142 (Supplement 1): 6981.

https://doi.org/10.1182/blood-2023-174062

Published: 2023

Journal Articles

Real-World Effectiveness and Safety of Hetrombopag for Delayed Platelet Engraftment Post-Allogeneic Hematopoietic Stem Cell Transplantation

JUN Zhu, Yun Lou, Chuxian Zhao, Ying Jiang, Daolin Wei, Chun Wang, Shan Shao, Huixia Liu, Su Li

Blood (2023) 142 (Supplement 1): 6950.

https://doi.org/10.1182/blood-2023-178605

Published: 2023

Journal Articles

Short-Term Substitution of Calcineurin Inhibitors (CNIs) with Recombinant Humanized Anti-CD25 Monoclonal Antibody (anti-CD25 rhMAb) As aGVHD Prophylaxis in Cnis Intolerant Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Shan Shao, Huixia Liu, Ying Jiang, Su Li, Daolin Wei, JUN Zhu, Chun Wang, Chuxian Zhao

Blood (2023) 142 (Supplement 1): 7007.

https://doi.org/10.1182/blood-2023-173673

Published: 2023

Journal Articles

Impact of Immunosuppression Intensified Conditioning Regimen for Patients with Strong Positive Pre-Transplantation Donor Specific Anti-HLA Antibodies (DSAs) Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

Huixia Liu, Daolin Wei, Shan Shao, Ying Jiang, Su Li, JUN Zhu, Chun Wang, Chuxian Zhao

Blood (2023) 142 (Supplement 1): 6989.

https://doi.org/10.1182/blood-2023-174240

Published: 2023

Journal Articles

Identification of a Novel FAM135B Cancer Susceptibility Mutation in a Family with Multiple Cases of MLL -Rearranged AML

Li-li PAN, Yanling Sun, Xiaolin Lai, Luya Ye, Xue-chun Wang, Zhi-xiang Chen, Yuanhua Cai, Yi Zheng, Yang Li, Ya-ping Wang, Xin Liu, Shao-yuan Wang, Qian-fei Wang

Blood (2022) 140 (Supplement 1): 9107.

https://doi.org/10.1182/blood-2022-165170

Published: 2022

Journal Articles

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Su Li, master's degree, Xianmin Song, MD, Liping Wan, Chun Wang, Yin Tong, Master's degree, Chongmei Huang, MD, Xiaoqian Xu, Master's degree, Yu CAI, MD, Guogang Xie, MD, Rong Tang, MD, Yi Sun, PhD, Aihua Bao, MD, Jun Yang, MD

Blood (2019) 134 (Supplement_1): 4626.

https://doi.org/10.1182/blood-2019-127950

Published: 2019

Journal Articles

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Jun Yang, Jiang Jieling, Yu CAI, MD, Su Li, Liping Wan, Jun Zhu, Huixia Liu, Shan Shao, Haitao Bai, Chun Wang, Jiong Hu, MD, Xianmin Song

Blood (2018) 132 (Supplement 1): 4575.

https://doi.org/10.1182/blood-2018-99-110727

Published: 2018

Journal Articles

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

Yu CAI, MD, Chun Wang, Xianmin Song, Liping Wan, Su Li, Jun Yang, Jieling Jiang, MD

Blood (2018) 132 (Supplement 1): 5758.

https://doi.org/10.1182/blood-2018-99-111868

Published: 2018

Journal Articles

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

Fan Yi Meng, MD, Ling Jiang, MD PhD, Qingxiu Zhong, MD, Li Chun Wang, MD, Guopan Yu, MD, Xinhua Zhu, MD

Blood (2014) 124 (21): 5953.

https://doi.org/10.1182/blood.V124.21.5953.5953

Published: 2014

Journal Articles

MiR-146a Expression Level As a Molecular Marker in Acute Promyleocytic Leukemia

Hua Zhong, Chun Wang, Chen Fangyuan, Lan Xu, Jihua Zhong, HU Jiong

Blood (2012) 120 (21): 4821.

https://doi.org/10.1182/blood.V120.21.4821.4821

Published: 2012

Journal Articles

Re-Assessment of the Prognostic Value of International Prognostic Index (IPI) and Revised IPI (R-IPI) in Patients with Diffuse Large B-Cell Lymphoma Treated with or without Rituximab in Chinese Populations: A Retrospective Multicenter Study by Shanghai Lymphoma Research Group

Honghui Huang, Fei Xiao, Fangyuan Chen, Ting Wang, Junmin Li, Jianmin Wang, Junning Cao, Chun Wang, Shanhua Zou

Blood (2011) 118 (21): 2649.

https://doi.org/10.1182/blood.V118.21.2649.2649

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) with FBA/FBAA Regimen Based Reduced-Intensity Conditioning: A Multicenter Clinical Trial in China

Jianmin Wang, Weiping Zhang, Jiong Hu, Chun Wang, Xinghua Chen, Jian Hou, MD, Yongping Song

Blood (2011) 118 (21): 1953.

https://doi.org/10.1182/blood.V118.21.1953.1953

Published: 2011

Journal Articles

Leukemia Cell-Derived Exosomes Targeted Dendritic Cells Can Induce More Strong Anti-Leukemia Response Than Exosomes Alone

Chang Sheng, Jing Sun, Chun Wang, Siguo Hao, Sr.

Blood (2011) 118 (21): 4278.

https://doi.org/10.1182/blood.V118.21.4278.4278

Published: 2011

Journal Articles

Reduced-Intensity Conditioning with FBA/FBAA Regimen Is Feasible for Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML): Interim Results of a Multicenter Clinical Trial in China.

Jianmin Wang, M.D., Jiong Hu, M.D., Chun Wang, M.D., Xinghua Chen, M.D., Jian Hou, M.D., Weiping Zhang, M.D., Wei Tang, M.D., Shike Yan, M.D., Xi Zhang, M.D., Lili Zhou, M.D., Jun Hou, M.D.

Blood (2009) 114 (22): 196.

https://doi.org/10.1182/blood.V114.22.196.196

Published: 2009

Journal Articles

PAD Induction Therapy Followed by Autologous Peripheral Blood Stem Cell Transplant (APBSCT) as Upfront Treatment for Myeloma (MM) in Chinese Patients.

Albert Kwok Wai Lie, DePei Wu, Chun Wang, Chor Sang Chim, Raymond Liang, Zhengzheng Fu, Liping Wan

Blood (2009) 114 (22): 4367.

https://doi.org/10.1182/blood.V114.22.4367.4367

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation Following Reduced Intensity Conditioning Regimen for Treatment of Refractory Leukemia

Jieling Jiang, Chun Wang, professor, Shike Yan

Blood (2008) 112 (11): 4425.

https://doi.org/10.1182/blood.V112.11.4425.4425

Published: 2008

Journal Articles

The Incidence and Outcome of Acute Lymphoblastic Leukemia in Shanghai, China Over 5 Years (2002–2006)

Xiong Ni, Zhixiang Shen, Fangyuan Chen, Hui Liang, Fengjuan Lu, Jingyan Tang, Chun Wang, Jingbo Shao, Jian Hou, Shanhua Zou, Jianmin Wang

Blood (2008) 112 (11): 3946.

https://doi.org/10.1182/blood.V112.11.3946.3946

Published: 2008

Journal Articles

VAMP-8 segregates mast cell–preformed mediator exocytosis from cytokine trafficking pathways

Neeraj Tiwari, Cheng-Chun Wang, Cristiana Brochetta, Gou Ke, Francesca Vita, Zeng Qi, Juan Rivera, Maria Rosa Soranzo, Giuliano Zabucchi, Wanjin Hong, Ulrich Blank

Blood (2008) 111 (7): 3665–3674.

https://doi.org/10.1182/blood-2007-07-103309

Published: 2008

Includes: Supplemental data

Journal Articles

Comparison of 12-Month Treatment Costs for Patients with Advanced Phase Chronic Myeloid Leukemia (CML) in China: Imatinib (IM) vs. Chemotherapy (Chemo) Plus Interferon-(IFN) in Accelerated Phase (AP) CML and IM vs. Chemo in Blast Crisis (BC) CML.

Zi Chen, M.D., Ph.D., Chun Wang, M.D., Weiwei Feng, PhD

Blood (2007) 110 (11): 5169.

https://doi.org/10.1182/blood.V110.11.5169.5169

Published: 2007

Journal Articles

Imatinib Is Cost-Effective Comparing to Interferon-(IFN) for Patients with Newly Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) from the Chinese Public Healthcare System Perspective.

Chun Wang, M.D., Zi Chen, M.D., Ph.D., Weiwei Feng, PhD

Blood (2007) 110 (11): 5170.

https://doi.org/10.1182/blood.V110.11.5170.5170

Published: 2007

NARROW

TBI/Ratg-Based Conditioning for Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in 11 Cases of Chemotherapy-Resistant Advanced-Stage Peripheral T-Cell Lymphoma

Real-World Effectiveness and Safety of Hetrombopag for Delayed Platelet Engraftment Post-Allogeneic Hematopoietic Stem Cell Transplantation

Short-Term Substitution of Calcineurin Inhibitors (CNIs) with Recombinant Humanized Anti-CD25 Monoclonal Antibody (anti-CD25 rhMAb) As aGVHD Prophylaxis in Cnis Intolerant Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Immunosuppression Intensified Conditioning Regimen for Patients with Strong Positive Pre-Transplantation Donor Specific Anti-HLA Antibodies (DSAs) Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

Identification of a Novel FAM135B Cancer Susceptibility Mutation in a Family with Multiple Cases of MLL -Rearranged AML

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

MiR-146a Expression Level As a Molecular Marker in Acute Promyleocytic Leukemia

Re-Assessment of the Prognostic Value of International Prognostic Index (IPI) and Revised IPI (R-IPI) in Patients with Diffuse Large B-Cell Lymphoma Treated with or without Rituximab in Chinese Populations: A Retrospective Multicenter Study by Shanghai Lymphoma Research Group

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) with FBA/FBAA Regimen Based Reduced-Intensity Conditioning: A Multicenter Clinical Trial in China

Leukemia Cell-Derived Exosomes Targeted Dendritic Cells Can Induce More Strong Anti-Leukemia Response Than Exosomes Alone

Reduced-Intensity Conditioning with FBA/FBAA Regimen Is Feasible for Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML): Interim Results of a Multicenter Clinical Trial in China.

PAD Induction Therapy Followed by Autologous Peripheral Blood Stem Cell Transplant (APBSCT) as Upfront Treatment for Myeloma (MM) in Chinese Patients.

Allogeneic Stem Cell Transplantation Following Reduced Intensity Conditioning Regimen for Treatment of Refractory Leukemia

The Incidence and Outcome of Acute Lymphoblastic Leukemia in Shanghai, China Over 5 Years (2002–2006)

VAMP-8 segregates mast cell–preformed mediator exocytosis from cytokine trafficking pathways

Comparison of 12-Month Treatment Costs for Patients with Advanced Phase Chronic Myeloid Leukemia (CML) in China: Imatinib (IM) vs. Chemotherapy (Chemo) Plus Interferon-(IFN) in Accelerated Phase (AP) CML and IM vs. Chemo in Blast Crisis (BC) CML.

Imatinib Is Cost-Effective Comparing to Interferon-(IFN) for Patients with Newly Diagnosed Chronic-Phase (CP) Chronic Myeloid Leukemia (CML) from the Chinese Public Healthcare System Perspective.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only